Back

State-of-the-art lecture on real-world evidence in cardio-oncology

28 August 2026 (13:45 - 14:03)
Organised by: Logo
Congress Presentation Part of: Real-world evidence in cardio-oncology: what is it and what can it tell us? Cardio-Oncology ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Pietro Ameri

University of Genoa, Genova (Italy)

3 More presentations in this session

Presentation thumbnail
Upfront immune checkpoint inhibitors and long-term risk of major adverse cardiovascular events: a population-based propensity-matched cohort study
Doctor I. Nardi Agmon (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Semaglutide provides cardio-protection in anthracycline-treated non-hodgkin lymphoma: a propensity-matched real-world study
Associate Professor C. Filippatos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of heart transplant recipients with a history of malignancy: a nationwide population-based cohort study
Professor J. Youn (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Real-world evidence in cardio-oncology: what is it and what can it tell us?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 13:45 CET
You may be interested in
thumbnail
Congress Session
Diagnosis and early management of cancer therapy–related cardiotoxicity
20 June 2026
thumbnail
Congress Presentation
What can robust real-world evidence bring to the table?
26 August 2022
thumbnail
Congress Session
Methods toolbox: evidence synthesis in cardiac rehabilitation
24 April 2026
thumbnail
Congress Presentation
Time to use SGLT2-inhibitors in cardio-oncology? - pro
20 June 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources